The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of RRx-001 on nephrotoxicity of cisplatin/etoposide in patients with solid tumors.
 
Nacer Abrouk
Consulting or Advisory Role - EpicentRx
 
Pedro Cabrales
Consulting or Advisory Role - EpicentRx
Research Funding - EpicentRx
 
Bryan Oronsky
Employment - EpicentRx
Leadership - EpicentRx
Stock and Other Ownership Interests - EpicentRx
Travel, Accommodations, Expenses - EpicentRx
 
Scott Caroen
Employment - EpicentRx
Stock and Other Ownership Interests - EpicentRx
Patents, Royalties, Other Intellectual Property - Scott Caroen is on patents relating to EpicentRx, Inc., technologies.
 
Tony R. Reid
Employment - EpicentRx
Leadership - EpicentRx
Stock and Other Ownership Interests - EpicentRx
Patents, Royalties, Other Intellectual Property - EpicentRx